Melatonin or low-dose quetiapine for insomnia in psychiatric disorders
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests if melatonin, a low dose of quetiapine, or a placebo can help people with a psychiatric condition who also have trouble sleeping. You may qualify if you have insomnia at least 3 times a week and your sleep problem has lasted 3 months or longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 16 and 64 years old.
- You have a current or past mental health diagnosis (such as depression, anxiety, bipolar, ADHD, or autism).
- You have had trouble sleeping at least 3 times a week for the last 3 months.
- You have an Insomnia Severity Index score of 11 or higher.
- You are not currently taking melatonin or quetiapine.
- If you are a woman able to become pregnant, you must have a negative pregnancy test and use effective birth control.
- You do not have severe health conditions, a BMI of 35 or higher, or recent alcohol/substance dependency.
- You can understand and speak Danish well enough to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new inhaled form of melatonin to help adults aged 55 and older with insomnia fall asleep faster. It compares the inhaled melatonin to a placebo to see if it improves sleep and is safe.
This trial tests a new inhaled form of melatonin, a natural sleep hormone, for adults aged 55 and older with insomnia. It aims to see how the medication works in the body and if it can help you fall asleep faster.
This study compares how well different over-the-counter and prescription sleep medications work for insomnia. Researchers will guide you through trying medications one at a time to find what works best for your sleep problems.
This study tests whether adding a melatonin supplement to a type of talk therapy for insomnia (called CBT-I) helps older adults sleep better. It aims to improve sleep quality and reduce insomnia symptoms.
This trial studies whether timed light exposure can help people who have trouble falling asleep. It aims to improve insomnia symptoms by testing a light-based approach while carefully measuring sleep patterns.
This study tests behavioral (non-medication) treatments to help adults with insomnia who have socioeconomic disadvantages access better care through primary care clinics. You may be asked about sleep symptoms, mental health, substance use, and daily schedule to see if the treatment is safe and likely to help you.
Hear when a new Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.